Is UnitedHealth Group Incorporated (UNH) the Best Stock to Invest in for Medium Term?
Wolfe Research Adjusts Price Target on UnitedHealth to $600 From $589
Jim Cramer Says UnitedHealth Group Inc. (UNH) Is An 'Unusual Rate Cut Winner'
Prominent Wall Street short sellers: Investors should focus on defensive stocks earnings and wait for clearer employment data.
Morgan Stanley maintains a neutral stance on defensive stocks related to cyclical sectors in the economy, waiting for 'clearer' employment data. The bank believes employment data is a key driving factor for the year-end stock market.
Is UnitedHealth Group Incorporated's (NYSE:UNH) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?
Harris accepted CNN's invitation for the second debate and called on Trump to "fight again."
①Harris posted on social media platform, saying:"I am glad to accept the second presidential debate on October 23rd, and I hope Trump can join." ②Currently, Trump's campaign team has not responded to Harris's invitation.
Express News | Optum Rx Responds to FTC Action
The Dow at 50,000. How It Could Happen -- and When. -- Barrons.com
Sector Update: Health Care Stocks Softer Friday Afternoon
FTC Sues PBMs of CVS, Cigna, UnitedHealth for Allegedly Inflating Insulin Prices
FTC 'Deeply Troubled' by Drug Manufacturers' Role in Raising Prices -- WSJ
FTC Sues Pharmacy Benefit Managers CVS Caremark, Express Scripts, OptumRx -- WSJ
PBMs' Strategy of Negotiating Rebates for Themselves Raised List Prices for Insulin, Was Unfair to Consumers, FTC Suit Says -- WSJ
Express News | The Federal Trade Commission (FTC) has sued the pharmacy chain CVS, Cigna, and UnitedHealth (UNH), accusing these intermediaries of allegedly raising insulin prices.
Express News | U.S. FTC Sues Units of CVS Health , Cigna , and UnitedHealth for Allegedly Artificially Inflating Insulin Prices
Express News | FTC Alleges Pharmacy Benefit Managers Systematically Excluded Cheaper Insulins in Exchange for Expensive, Highly Rebated Alternatives
Express News | FTC Case Does Not Name Insulin Drugmakers Eli Lilly , Novo Nordisk , and Sanofi , but Agency Reserves Right to Sue Later
Cantor Fitzgerald Reiterates Overweight on UnitedHealth Group, Maintains $591 Price Target
UnitedHealth Group Analyst Ratings
UnitedHealth at 19.09X P/E: Worth the Price or Time to Take Profits?